Sanofi
SNYNF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001121404
No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2.52M in total; no superinvestor holds it.
Other share classesSNY
Holders of 5% or more of SNYNF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sanofi, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 5.80%72.1M shares | – | Apr 23, 20251 filing | Apr 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Sanofi, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 23, 20257:39 PM ET | BlackRock, Inc. | 13G/A | 5.80%72.1M shares | – | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sanofi shares.
No Form 144 notices for Sanofi are on file.